Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heavy metal containing doai
Patent
1987-09-24
1990-09-11
Griffin, Ronald W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heavy metal containing doai
424 46, 424 48, 424439, 424440, 424441, 424442, 424464, 424489, 424641, 424643, 514888, A61K 910, A61K 968, A61K 31315, A61K 3330
Patent
active
049563858
ABSTRACT:
This invention discloses and claims improved methods to reduce duration of common colds in humans through use of pharmaceutically acceptable zinc compounds topically and frequently applied to the oral mucosa by various means. The invention improves upon the prior art using zinc gluconate throat lozenges to reduce the duration of common colds and zinc borate intranasally as an astringent and decongestant in treatment of common colds.
REFERENCES:
patent: 944738 (1909-12-01), Loose et al.
patent: 4367218 (1983-01-01), Jacobson
patent: 4444755 (1984-04-01), Horrobin
patent: 4469674 (1984-09-01), Shah, et al.
Handbook of Nonprescription Drugs, 6th ed., American Pharmaceutical Association, p. 317.
The Pharmacological Pharmacological Basis of Therapeutics, 5th ed., ed. by Goodman and Gilman, Macmillan Publishing Co., Inc., 1975, pp. 1000-1001.
Gutman, Modern Drug Encyclopedia and Therapeutic Guide, New Modern Drugs, N.Y., p. 731.
Bailey, British Medical Journal, Apr. 17, 1973, p. 808.
Merck's 1901 Manual, Merck and Co., N.Y., pp. 124-126.
Merck's Manual of the Materia, Medica, 5th ed., Merck and Co., N.Y., 1923, pp. 160-161.
Howard, Modern Drug Encyclopedia, 6th ed., Drug Publications, Inc., N.Y., p. 1168.
Korant, Nature, 248, 1974, pp. 588-590.
Korant, Chem. Abst., vol. 85, p. 76, 1976, Abst. No. 814y.
Franklin, Brit. Med. Journal, pp. 1115-1116, 1931.
Shields, The Practitioner, pp. 645-648, 1936 (copy attached).
Eby, et al. (Jan. 1984), Antimicrobial Agents and Chemo., 25:20-24.
The Merck Index, 10th edition, 1983, pp. 1455-1458.
Eby (Nov. 1980), "Zinc in Leukemia . . . ".
Korant (1979), "Role of Cellular and Viral Proteases".
Korant, et al. (1976), Jrnl. Virol., 18:298-306.
Butterworth, et al. (1976), Arch Virol., 51:169-189.
Korant, et al. (1973), "Zinc Ions Inhibit Replication of Rhinoviruses".
Morone, et al. (1980), Jrn. All. Clin. Immunol., 65:171.
Howard, Modern Drug Encyclopedia.
Gutman (1941), Modern Drug Encyclopedia.
Shields (1936), "The Ionization Treatment of Hay Fever", pp. 645-648.
Godfrey (1988), Antimicrob. Agents Chemother.,32:605.
Farr et al. (1988). Antimicrob Agents Chemothr., 32:607.
Martin (1988), Antimicrob. Agents Chemother., 32:600.
Farr et al. (1987), Antimicrob. Agents Chemother., 31:1183.
Al-Nakib et al. (1987), Jrnl. Antimicrob. Chemother., 20:893.
Pasternak (1987), Bioscience Rep., 7(02):81.
"Zinc Zaps Common Cold" (1987), The Evening Wellington, New Zealand.
Zerial et al. (1985), Antimicrob. Agents Chemother., 27(5):846.
"Zinc vs Colds" (1984), Austin American Statesman, Dec. 2, 1984, p. A15.
Eby et al. (1988), Antimicrob. Agents Chemother., 32:606.
Couch (1984), Jrnl. Infect. Dis., 150(2):174.
Hayden et al. (1984) Jrnl. Infect. Dis., 150(2):174.
Samo et al. (1984), Jrnl. Infect. Dis., 150(2):181.
Phillpotts et al. (1983) Antimicrob. Agents Chemother., 23(5):671.
Anderson et al. (1983), "Viral Respiratory Illnesses", Medical Clinics of North America, 67(5):1009.
Levandowski et al. (1982), Antimicrob. Agents Chemother., 22(6):1004.
Andermann et al. (1982), Eur. Jrnl. Drug Metab. Pharma., 7(8):233.
Hayden et al. (1982), Antimicrob. Agents Chemother., 21(6):892.
"Idoxuridine and Some Other Antiviral Agents" (1982), Martindale, The Extra Pharmacopoeia, 28th Edition, pp. 820-827.
Giron (1982), Proc. Soc. Exp. Biol. Med., 170.25.
Korant (1979) "Inhibition of Viral Protein Cleavage", in Design of Inhibitor of Viral Functions, I. Gauri, ed., Academic Press.
Korant (1979), "Role of Cellular and Viral Proteases . . ." in The Molecular Biology of Picornoviruses, pp. 149-173.
Webster's New Collegiate Dictionary (1979), "lozenge and troche".
Butterworth et al. (1976), Arch. Virol., 51:109.
Harmon et al. (1976), Proc. Soc. Exp. Biol. Med., 152:598.
1948 Quarterly Cumulative Index Medicus, vol. 44, p. 797.
Van Voris, "Antiviral Chemotherapy", Chapter 8 in Textbook of Human Virology, pp. 193-229.
Levandowski, "Rhinoviruses", Chapter 16 in Textbook of Human Virology, pp. 391-405.
Tyrrell et al., "Antirhinovirus Drugs", pp. 340-341.
Chapter 57, "Antiviral Chemotherapy & Prophylaxis," in Review of Medical Pharmacology, 7th Edition, Meyers et al. eds., pp. 589-592.
Akzo Chemie "Gluconates", pp. 5-15.
LandOfFree
Method for reducing the duration of the common cold does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for reducing the duration of the common cold, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for reducing the duration of the common cold will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1185097